The Supervisory Board of ROHM Group announces the appointment of Dr. Hans Bohnen as Managing Director of ROHM Group with effect from February 1, 2024. Dr. Hans Bohnen will succeed Michael Pei
Pack, who has 34 years of successful experience in the chemical industry, including the last 10 years in the leadership of the MMA/PMMA (methyl methacrylate/polymethyl methacrylate) business, has decided to Withdrew from operating business and retired on March 1.
Ronald Ayles, managing partner of Roma investor Advent Capital, said: “We would like to express our gratitude to Michael
Pack expresses his heartfelt thanks. As CEO, he had a decisive influence on the establishment and continuous development of ROHM, implementing the growth strategy in a decisive and team-oriented manner. ”
Dr. Yu Dahai, Chairman of the ROHM Supervisory Board, emphasized: “Michael
Pack has successfully led the company through the COVID-19 period and promoted many major projects, such as the construction of the LiMA factory and the acquisition of SABIC (Saudi Basic Industries Corporation) film and sheet business. We deeply regret his decision to retire and wish him all the best for the future. ”
As a long-term plan, this high-level change of ROHM will be carried out during the first quarter of next year, and a smooth transition will be achieved through joint management handover.
“Rohm’s goal is to become the world’s leading integrated methacrylates company and at the same time to further expand the company’s technology leadership. I will actively participate in shaping this goal.” Hans
Bohnen emphasized the motivation behind his new job. Ronald Ayles said: “Hans
Dr. Bohnen is a seasoned industry expert who will bring international experience from different chemical companies to his new position, as well as comprehensive expertise in different markets, technologies and strategies. ”
Dr. Hans Bohnen has successfully held international management positions in a number of chemical companies in recent years. He is a member of the Hoechst Group
AG, before moving to Celanese, SGL Carbon and strategic consulting firm Booz Allen
Hamilton held various management positions.
In 2018, Dr. Hans Bohnen was appointed Clariant
AG), where he led and managed the Care Chemicals, Catalysts and Renewables business units. In addition, Dr. Hans Bohnen is responsible for Purchasing and Technology as well as the North and South America regions. Mid-2023, Hans
Dr. Bohnen has been appointed Group CEO of Hydrogen Chemistry Corporation (HyCC).
“We are delighted to announce Dr. Hans Bohnen as the new CEO of ROHM and are confident that he will work closely with his colleagues Dr. Hans-Peter Hauck and Martin
Together with Krämer, we continue to promote the established strategy and successfully lead ROHM into the future. ” Dr. Yu Dahai concluded.
微信扫一扫打赏
